Current issues in Hereditary Angioedema (HAE) - Ipopi

Current issues in Hereditary Angioedema (HAE) - Ipopi Current issues in Hereditary Angioedema (HAE) - Ipopi

27.01.2015 Views

Icatibant (Firazyr) • Subcutaneous bradykinin inhibitor – Local pain & swelling ‘giant bee-sting’ – Almost anyone can learn – Risks: large swelling, patient with frequent attacks • Ideal for self administration • Speed of onset of relief and resolution broadly equivalent to C1 inhibitor t=0 min t=30 min

Icatibant (Firazyr) • Recurrent attacks – Usually slow onset – May occasionally be fast – 10% need retreatment • Risk of recurrence increased if: – Large swelling/severe attack – Late in course of attack – Very frequent attacks (>1/week) Always have second syringe available- will be effective

Icatibant (Firazyr)<br />

• Recurrent attacks<br />

– Usually slow onset<br />

– May occasionally be fast<br />

– 10% need retreatment<br />

• Risk of recurrence <strong>in</strong>creased if:<br />

– Large swell<strong>in</strong>g/severe attack<br />

– Late <strong>in</strong> course of attack<br />

– Very frequent attacks (>1/week)<br />

Always have second syr<strong>in</strong>ge available- will be effective

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!